% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Reijs:138197,
      author       = {Reijs, Babette L R and Teunissen, Charlotte E and
                      Goncharenko, Nikolai and Betsou, Fay and Blennow, Kaj and
                      Baldeiras, Inês and Brosseron, Frederic and Cavedo, Enrica
                      and Fladby, Tormod and Froelich, Lutz and Gabryelewicz,
                      Tomasz and Gurvit, Hakan and Kapaki, Elisabeth and Koson,
                      Peter and Kulic, Luka and Lehmann, Sylvain and Lewczuk,
                      Piotr and Lleó, Alberto and Maetzler, Walter and de
                      Mendonça, Alexandre and Miller, Anne-Marie and Molinuevo,
                      José L and Mollenhauer, Brit and Parnetti, Lucilla and Rot,
                      Uros and Schneider, Anja and Simonsen, Anja Hviid and
                      Tagliavini, Fabrizio and Tsolaki, Magda and Verbeek, Marcel
                      M and Verhey, Frans R J and Zboch, Marzena and Winblad,
                      Bengt and Scheltens, Philip and Zetterberg, Henrik and
                      Visser, Pieter Jelle},
      title        = {{T}he {C}entral {B}iobank and {V}irtual {B}iobank of
                      {BIOMARKAPD}: {A} {R}esource for {S}tudies on
                      {N}eurodegenerative {D}iseases.},
      journal      = {Frontiers in neurology},
      volume       = {6},
      issn         = {1664-2295},
      address      = {Lausanne},
      publisher    = {Frontiers Research Foundation},
      reportid     = {DZNE-2020-04519},
      pages        = {216},
      year         = {2015},
      abstract     = {Biobanks are important resources for biomarker discovery
                      and assay development. Biomarkers for Alzheimer's and
                      Parkinson's disease (BIOMARKAPD) is a European multicenter
                      study, funded by the EU Joint Programme-Neurodegenerative
                      Disease Research, which aims to improve the clinical use of
                      body fluid markers for the diagnosis and prognosis of
                      Alzheimer's disease (AD) and Parkinson's disease (PD). The
                      objective was to standardize the assessment of existing
                      assays and to validate novel fluid biomarkers for AD and PD.
                      To support the validation of novel biomarkers and assays, a
                      central and a virtual biobank for body fluids and associated
                      data from subjects with neurodegenerative diseases have been
                      established. In the central biobank, cerebrospinal fluid
                      (CSF) and blood samples were collected according to the
                      BIOMARKAPD standardized pre-analytical procedures and stored
                      at Integrated BioBank of Luxembourg. The virtual biobank
                      provides an overview of available CSF, plasma, serum, and
                      DNA samples at each site. Currently, at the central biobank
                      of BIOMARKAPD samples are available from over 400 subjects
                      with normal cognition, mild cognitive impairment (MCI), AD,
                      frontotemporal dementia (FTD), vascular dementia, multiple
                      system atrophy, progressive supranuclear palsy, PD, PD with
                      dementia, and dementia with Lewy bodies. The virtual biobank
                      contains information on over 8,600 subjects with varying
                      diagnoses from 21 local biobanks. A website has been
                      launched to enable sample requests from the central biobank
                      and virtual biobank.},
      cin          = {AG Heneka / AG Maetzler / AG Schneider Göttingen},
      ddc          = {610},
      cid          = {I:(DE-2719)1011303 / I:(DE-2719)5000024 /
                      I:(DE-2719)1440011},
      pnm          = {344 - Clinical and Health Care Research (POF3-344)},
      pid          = {G:(DE-HGF)POF3-344},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:26528237},
      pmc          = {pmc:PMC4606063},
      doi          = {10.3389/fneur.2015.00216},
      url          = {https://pub.dzne.de/record/138197},
}